Optimization of immunotherapy in elderly cancer patients.

Optimization of immunotherapy in elderly cancer patients.

Item
http://www.wikidata.org/entity/Q37650300
Inhibiting Immune Checkpoints for the Treatment of Bladder CancerCAR-modified T-cell therapy for cancer: an updated review.Preoperative lymphocyte-to-monocyte ratio predicts survival in primary hepatitis B virus-positive hepatocellular carcinoma after curative resection.Adjuvant Weekly Girentuximab Following Nephrectomy for High-Risk Renal Cell Carcinoma: The ARISER Randomized Clinical Trial.Cancer Immunotherapies: Are They as Effective in the Elderly?Checkpoint inhibition and melanoma: Considerations in treating the older adult.Treatment of head and neck cancer in the elderly.The role of checkpoint inhibitors immunotherapy in advanced non-small cell lung cancer in the elderly.Aging: T cell metabolism within tumorsCurrent status and perspectives in immunotherapy for metastatic melanoma.
P2860

Optimization of immunotherapy in elderly cancer patients.

Item
http://www.wikidata.org/entity/Q37650300
description
article científic
@ca
article scientifique
@fr
articolo scientifico
@it
artigo científico
@pt
bilimsel makale
@tr
scientific article published on January 2013
@en
vedecký článok
@sk
vetenskaplig artikel
@sv
videnskabelig artikel
@da
vědecký článek
@cs
name
Optimization of immunotherapy in elderly cancer patients.
@en
Optimization of immunotherapy in elderly cancer patients.
@nl
type
label
Optimization of immunotherapy in elderly cancer patients.
@en
Optimization of immunotherapy in elderly cancer patients.
@nl
prefLabel
Optimization of immunotherapy in elderly cancer patients.
@en
Optimization of immunotherapy in elderly cancer patients.
@nl
P1433
P1476
P2093
P2860
P304
P31
P356
P407
P433
P478
P577
P698
P921
P932
P356
P1433
P1476
Optimization of immunotherapy in elderly cancer patients.
@en
P2093
P2860
P304
P31
P356
10.1615/CRITREVONCOG.2013010591
P407
P433
P478
P577
P698
P921
P932